Novartis

$87.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-0.24%) Today
+$0.24 (+0.27%) As of 8:07 AM EST after-hours

Why Robinhood?

You can buy or sell Novartis and other stocks, options, and ETFs commission-free!

About NVS

Novartis AG, also called Novartis, is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland. The listed name for NVS is Novartis AG.

CEO
Vasant Narasimhan
Employees
103,914
Headquarters
Basel, Basel-Stadt (Basle Town)
Founded
1996
Market Cap
192.49B
Price-Earnings Ratio
27.92
Dividend Yield
2.29
Average Volume
2.12M
High Today
$87.40
Low Today
$86.94
Open Price
$87.18
Volume
2.81M
52 Week High
$99.84
52 Week Low
$69.18

Collections

NVS News

Benzinga54m

Novartis Kicks Off $2.5B Share Buyback Program On Strong Pipeline Growth

On Tuesday, Swiss biopharma company Novartis AG (NYSE: NVS) announced a $2.5 billion share buyback program. The management also exhibited a heightened confidenc
MarketWatch6h

Novartis to repurchase up to $2.5 billion shares

Novartis AG said Tuesday it is initiating a share-buyback program of up to $2.5 billion that will start immediately and last into the first half of 2021. The S
BenzingaNov 19

Price Over Earnings Overview: Novartis

Looking into the current session, Novartis Inc. (NYSE: NVS) shares are trading at $86.24, after a 0.51% gain. Moreover, over the past month, the stock increased

NVS Earnings

$0.00
$0.52
$1.04
$1.56
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Available Jan 26, Pre-Market

You May Also Like